Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. More Details
Reasonable growth potential and slightly overvalued.
Share Price & News
How has Wright Medical Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: WMGI has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: WMGI exceeded the US Medical Equipment industry which returned 23.8% over the past year.
Return vs Market: WMGI exceeded the US Market which returned 17.8% over the past year.
Price Volatility Vs. Market
How volatile is Wright Medical Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StHow Much Is Wright Medical Group N.V. (NASDAQ:WMGI) Paying Its CEO?
1 month ago | Simply Wall StWright Medical Group N.V.'s (NASDAQ:WMGI) Intrinsic Value Is Potentially 75% Above Its Share Price
1 year ago | Simply Wall StIntroducing Wright Medical Group (NASDAQ:WMGI), The Stock That Dropped 24% In The Last Year
Is Wright Medical Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: WMGI ($30.64) is trading below our estimate of fair value ($54.17)
Significantly Below Fair Value: WMGI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: WMGI is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: WMGI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate WMGI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: WMGI is overvalued based on its PB Ratio (4.7x) compared to the US Medical Equipment industry average (4.1x).
How is Wright Medical Group forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WMGI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: WMGI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: WMGI's is expected to become profitable in the next 3 years.
Revenue vs Market: WMGI's revenue (11% per year) is forecast to grow faster than the US market (10% per year).
High Growth Revenue: WMGI's revenue (11% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: WMGI's Return on Equity is forecast to be low in 3 years time (7.5%).
How has Wright Medical Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WMGI is currently unprofitable.
Growing Profit Margin: WMGI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: WMGI is unprofitable, but has reduced losses over the past 5 years at a rate of 21.1% per year.
Accelerating Growth: Unable to compare WMGI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WMGI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.5%).
Return on Equity
High ROE: WMGI has a negative Return on Equity (-12.79%), as it is currently unprofitable.
How is Wright Medical Group's financial position?
Financial Position Analysis
Short Term Liabilities: WMGI's short term assets ($707.1M) do not cover its short term liabilities ($861.2M).
Long Term Liabilities: WMGI's short term assets ($707.1M) do not cover its long term liabilities ($861.4M).
Debt to Equity History and Analysis
Debt Level: WMGI's debt to equity ratio (139.7%) is considered high.
Reducing Debt: WMGI's debt to equity ratio has reduced from 259.5% to 139.7% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WMGI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if WMGI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Wright Medical Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate WMGI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate WMGI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if WMGI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if WMGI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of WMGI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Bob Palmisano (75 yo)
Mr. Robert J. Palmisano, also known as Bob, served as Chairman of the Board of Directors at Avedro Inc. since May 14, 2014 until November 21, 2019. He has been the Chief Executive Officer, President and Ex ...
CEO Compensation Analysis
Compensation vs Market: Bob's total compensation ($USD7.31M) is about average for companies of similar size in the US market ($USD5.63M).
Compensation vs Earnings: Bob's compensation has increased whilst the company is unprofitable.
|Executive VP and Chief Financial & Operations Officer||10.83yrs||US$2.39m||0.090% |
|Senior VP||8.83yrs||US$1.57m||0.043% |
|Executive VP & Chief Global Commercial Officer||1.75yrs||US$2.11m||0.051% |
|Senior Vice President of Operations||2.25yrs||US$1.33m||0.0049% |
|Senior VP & Chief Compliance Officer||6yrs||no data||0.020% |
|Senior VP & Chief Communications Officer||9yrs||no data||0.017% |
|Senior VP & Chief Human Resources Officer||2.58yrs||US$1.89m||0.0060% |
|Senior Vice President of Process Improvement||8.83yrs||no data||0.024% |
|Senior Vice President of Global Finance||8.42yrs||no data||0.025% |
|President of Emerging Markets||7.75yrs||US$2.57m||0.018% |
|President of Upper Extremities||4.33yrs||no data||0.017% |
Experienced Management: WMGI's management team is seasoned and experienced (8.1 years average tenure).
|Executive Director||0.50yr||no data||no data|
|Non-Executive Director||0.50yr||no data||no data|
|Independent Chairman of the Board||11.75yrs||US$365.22k||0.077% |
|Independent Non-Executive Director||5yrs||US$302.33k||0.0098% |
|Independent Non-Executive Director||13.75yrs||US$304.97k||0.035% |
|Independent Non-Executive Director||14.25yrs||US$311.67k||0.029% |
|Independent Non-Executive Director||12.75yrs||US$296.47k||0.058% |
|Independent Non-Executive Director||12.75yrs||US$293.72k||0.046% |
|Independent Non-Executive Director||5yrs||US$313.97k||0.013% |
|Non-Executive Director||0.50yr||no data||no data|
|Independent Non-Executive Director||2.33yrs||US$286.22k||no data|
Experienced Board: WMGI's board of directors are considered experienced (7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.
Wright Medical Group N.V.'s company bio, employee growth, exchange listings and data sources
- Name: Wright Medical Group N.V.
- Ticker: WMGI
- Exchange: NasdaqGS
- Founded: 1999
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$3.976b
- Shares outstanding: 129.68m
- Website: https://www.wright.com
Number of Employees
- Wright Medical Group N.V.
- Prins Bernhardplein 200
- 1097 JB
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|WMGI||NasdaqGS (Nasdaq Global Select)||Yes||Ordinary Shares||US||USD||Feb 2011|
|T98||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Feb 2011|
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Can ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/24 00:57|
|End of Day Share Price||2020/10/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.